Prolonged candidemia in patients with cancer

Clinical Infectious Diseases

Volumn 35, Issue 6, 2002, Pages 778-779

  Safdar, Amar ^a   Cross, Emily W ^b   Chaturvedi, Vishnu ^c   Perlin, David S ^b   Armstrong, Donald ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^c NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ANTIBIOTIC RESISTANCE; CANCER PATIENT; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDIASIS; FUNGUS ISOLATION; GRANULOCYTOPENIA; HUMAN; INFECTION SENSITIVITY; LETTER; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; RECURRENT DISEASE;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CATHETERS, INDWELLING; DNA, FUNGAL; HUMANS; MICROBIAL SENSITIVITY TESTS; NEOPLASMS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE;

EID: 0037105703     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/342568     Document Type: Letter

References (4)

1. Prospective study of Candida species in patients at a comprehensive cancer center
2. Prospective epidemiological analysis of triazole-resistant nosocomial Candida glabrata isolated from patients at a comprehensive cancer center
3. Should vascular catheters be removed from all patients with candidemia? An evidence-based review
4. High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptible to resistance